Ciencias de la Salud

URI permanente para esta comunidadhttp://repositorio.uta.edu.ec/handle/123456789/813

Examinar

Resultados de la búsqueda

Mostrando 1 - 2 de 2
  • Item type:Ítem,
    Relación entre el uso de anticonceptivos hormonales y alteraciones lipídicas en mujeres de edad fértil
    (2025-07-01)
    Pillapa Tubon Maybeline Mariuxi
    ;
    Guangasig Toapanta Víctor Hernán, Bq.F. Mg
    ;
    Universidad Técnica de Ambato / Facultad de Ciencias de la Salud / Carrera de Laboratorio Clínico
    Hormonal contraceptives, crucial for family planning, can induce lipid alterations that increase cardiovascular risk in women of reproductive age. This study examined their impact through a bibliographic review of research conducted between 2018 and 2024, using databases such as PubMed, Scielo, and Science Direct, with keywords like “hormonal contraceptives” and “lipid alterations.” Original studies, systematic reviews, and documents from organizations like the World Health Organization were included. The findings indicate that combined oral contraceptives increase total cholesterol, LDL, and triglycerides, and may reduce HDL, particularly in women with obesity or diabetes. Factors such as dose, duration of use, and self-medication exacerbate these effects, potentially leading to complications like severe hypertriglyceridemia. New formulations, such as estetrol, appear less harmful. It is concluded that, despite their benefits, hormonal contraceptives require regular lipid profile monitoring and personalized selection based on individual risk factors to minimize cardiovascular complications, emphasizing the need for longitudinal studies and adequate clinical oversight.
  • Item type:Ítem,
    Alteraciones en la serie roja y plaquetas asociadas al uso de anticonceptivos hormonales
    (2025-07-01)
    Escobar Beltrán, Jimmy Alexander
    ;
    Rosero Freire, Daniela Alexandra, Lcda. Mg.
    ;
    Universidad Técnica de Ambato / Facultad de Ciencias de la Salud / Carrera de Laboratorio Clínico
    Introduction. Hormonal contraceptives are widely used worldwide due to their effectiveness in preventing unwanted pregnancies. In addition to their contraceptive function, these drugs offer multiple non-contraceptive benefits, such as regulating the menstrual cycle, reducing pain associated with dysmenorrhea, decreasing excessive menstrual bleeding, and treating acne and polycystic ovary syndrome. However, various studies have shown that their use can induce changes in hematological parameters, particularly in the red cell series and platelets. These modifications vary depending on the type of contraceptive, the route of administration, and the duration of treatment. Objective. To analyze the alterations in red blood cell parameters and platelet count associated with the use of different types of hormonal contraceptives in women. Methodology. An information search was conducted in various databases, including PubMed, Scopus, BVS, Cochrane Library, Elsevier, and books, considering studies published in both English and Spanish. Results. Combined oral contraceptives and quarterly progestogen-only injections are associated with clear increases in red blood cell count, hemoglobin, hematocrit, and platelet count. In contrast, transdermal patches, the vaginal ring, and the hormonal IUD maintain stable erythrocyte indices and platelet counts. Subdermal implants, on the other hand, do not usually alter these parameters initially, but prolonged use can cause irregular uterine bleeding, which over time leads to a decrease in red blood cell count, hematocrit, MCV, and MCH due to the progressive depletion of iron stores. Conclusion. The hematological effects of hormonal contraceptives vary according to their type and duration of use. While combined oral contraceptives and injectable progestogens promote an increase in erythrocyte and platelet parameters due to reduced menstrual bleeding and possible erythropoietic stimulation, chronic use of subdermal implants may induce changes consistent with iron deficiency